<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7997205</article-id><article-id pub-id-type="pmid">33670999</article-id><article-id pub-id-type="doi">10.3390/nu13030798</article-id><article-id pub-id-type="publisher-id">nutrients-13-00798</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Coconut Oil Supplementation Does Not Affect Blood Pressure Variability and Oxidative Stress: A Placebo-Controlled Clinical Study in Stage-1 Hypertensive Patients</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3121-1890</contrib-id><name><surname>J&#x000fa;nior</surname><given-names>Francisco A. O.</given-names></name><xref ref-type="aff" rid="af1-nutrients-13-00798">1</xref></contrib><contrib contrib-type="author"><name><surname>Ruiz</surname><given-names>Clara R.</given-names></name><xref ref-type="aff" rid="af2-nutrients-13-00798">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1988-3996</contrib-id><name><surname>de Oliveira</surname><given-names>Yohanna</given-names></name><xref ref-type="aff" rid="af3-nutrients-13-00798">3</xref></contrib><contrib contrib-type="author"><name><surname>Barros</surname><given-names>Marco A. V.</given-names></name><xref ref-type="aff" rid="af4-nutrients-13-00798">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3576-9023</contrib-id><name><surname>Silva</surname><given-names>Alexandre S.</given-names></name><xref ref-type="aff" rid="af5-nutrients-13-00798">5</xref></contrib><contrib contrib-type="author"><name><surname>Santos</surname><given-names>Maria S. B.</given-names></name><xref ref-type="aff" rid="af5-nutrients-13-00798">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0327-538X</contrib-id><name><surname>Martins</surname><given-names>Vin&#x000ed;cius J. B.</given-names></name><xref ref-type="aff" rid="af1-nutrients-13-00798">1</xref></contrib><contrib contrib-type="author"><name><surname>Balarini</surname><given-names>Camille M.</given-names></name><xref ref-type="aff" rid="af1-nutrients-13-00798">1</xref></contrib><contrib contrib-type="author"><name><surname>Braga</surname><given-names>Valdir A.</given-names></name><xref ref-type="aff" rid="af2-nutrients-13-00798">2</xref><xref rid="c1-nutrients-13-00798" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Buscemi</surname><given-names>Silvio</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-nutrients-13-00798"><label>1</label>Health Sciences Center, Department of Physiology and Pathology, Federal University of Paraiba, Joao Pessoa 58051-900, Brazil; <email>junior.ltf@gmail.com</email> (F.A.O.J.); <email>viniciusjbmartins@gmail.com</email> (V.J.B.M.); <email>camille.balarini@gmail.com</email> (C.M.B.)</aff><aff id="af2-nutrients-13-00798"><label>2</label>Biotechnology Center, Federal University of Paraiba, Joao Pessoa 58051-900, Brazil; <email>clararittmeyer97@gmail.com</email></aff><aff id="af3-nutrients-13-00798"><label>3</label>Health Sciences Center, Department of Nutrition, Federal University of Paraiba, Joao Pessoa 58051-900, Brazil; <email>yoh_0806@hotmail.com</email></aff><aff id="af4-nutrients-13-00798"><label>4</label>Medical Sciences Center, Federal University of Paraiba, Joao Pessoa 58051-900, Brazil; <email>mavivo@cardiol.br</email></aff><aff id="af5-nutrients-13-00798"><label>5</label>Health Sciences Center, Department of Physical Education, Federal University of Paraiba, Joao Pessoa 58051-900, Brazil; <email>alexandresergiosilva@yahoo.com.br</email> (A.S.S.); <email>sbrasileiro@yahoo.com.br</email> (M.S.B.S.)</aff><author-notes><corresp id="c1-nutrients-13-00798"><label>*</label>Correspondence: <email>valdir@cbiotec.ufpb.br</email>; Tel.: +55-83-32167173</corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>2</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2021</year></pub-date><volume>13</volume><issue>3</issue><elocation-id>798</elocation-id><history><date date-type="received"><day>20</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>24</day><month>2</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="pmc" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Exploring an alternative to improve the clinical management of hypertension, we tested the hypothesis that food supplementation with coconut oil (EVCO), alone or combined with aerobic exercise training, could exert an antihypertensive effect (primary outcome) in patients with stage 1 hypertension. Forty-five hypertensive volunteers of both genders participated in a placebo-controlled clinical trial. The volunteers were submitted to 24-hour ambulatory blood pressure monitoring, analysis of blood pressure variability (BPV), measurement of serum malondialdehyde (MDA) and nutritional assessment. Results indicate that EVCO consumption had no adverse effects. The supplementation did not increase the caloric intake compared with placebo, and the dietary constituents were similar between groups, except for the saturated fats, especially lauric acid. The analysis of blood pressure indicated absence of antihypertensive effect of EVCO alone or combined with physical training. Furthermore, no effects on blood pressure variability and oxidative stress were observed in the supplemented hypertensive patients. Thus, despite the results observed in pre-clinical studies, the current clinical study did not provide evidence to support the use of coconut oil as an adjuvant in the management of hypertension in humans.</p></abstract><kwd-group><kwd>nutritional approach</kwd><kwd>cardiovascular system</kwd><kwd>hypertension</kwd><kwd>coconut oil</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-nutrients-13-00798"><title>1. Introduction</title><p>The impact of hypertension on health continues to rise despite the advances in antihypertensive drug development by the pharmaceutical industry. In 2018, data from the American Heart Association indicated that 40.6% of deaths from cardiovascular disease in the U.S. were related to hypertension [<xref rid="B1-nutrients-13-00798" ref-type="bibr">1</xref>] and in the year 2035 the costs related to hypertension will exceed 220 billion dollars. Hypertension is a pandemic disease that affects approximately one-third of the world population [<xref rid="B2-nutrients-13-00798" ref-type="bibr">2</xref>].</p><p>Non-pharmacological approaches have been important adjuncts in the treatment of hypertension. Nutritional strategies such as using antioxidants and regular exercise have been shown to be beneficial [<xref rid="B3-nutrients-13-00798" ref-type="bibr">3</xref>,<xref rid="B4-nutrients-13-00798" ref-type="bibr">4</xref>,<xref rid="B5-nutrients-13-00798" ref-type="bibr">5</xref>], but more consistent clinical evidence is needed to strengthen the role of these alternatives in the management of hypertension. A recent strategy that has been used is the intake of coconut oil due to its nutritional, medicinal and cosmetic uses [<xref rid="B6-nutrients-13-00798" ref-type="bibr">6</xref>].</p><p>It has been demonstrated that coconut oil can increase high-density lipoprotein, improving the lipid profile [<xref rid="B7-nutrients-13-00798" ref-type="bibr">7</xref>,<xref rid="B8-nutrients-13-00798" ref-type="bibr">8</xref>], and increase main enzymes involved with the redox balance [<xref rid="B8-nutrients-13-00798" ref-type="bibr">8</xref>,<xref rid="B9-nutrients-13-00798" ref-type="bibr">9</xref>,<xref rid="B10-nutrients-13-00798" ref-type="bibr">10</xref>]. Despite these findings, currently there is controversy over the effects of coconut oil on human health [<xref rid="B11-nutrients-13-00798" ref-type="bibr">11</xref>,<xref rid="B12-nutrients-13-00798" ref-type="bibr">12</xref>]. In the cardiovascular system, preclinical studies of our group showed that coconut oil supplementation, alone or combined with exercise training, was able to induce antihypertensive response in spontaneously hypertensive rats [<xref rid="B13-nutrients-13-00798" ref-type="bibr">13</xref>]. In addition, it was shown that this effect was associated with an improvement in baroreflex response and attenuation of oxidative stress. Subsequently, it was found that lauric acid, the main fatty acid isolated from coconut oil, was able to induce a dose-dependent reduction in blood pressure (BP), as well as to promote vasorelaxation of isolated rat superior mesenteric artery [<xref rid="B14-nutrients-13-00798" ref-type="bibr">14</xref>].</p><p>However, there are no reports on the effects of coconut oil supplementation in relation to the cardiovascular system in humans. Studies that focus on the relationship of coconut oil consumption with physiological variables of interest such as BP and BP variability can elucidate the potential of coconut oil as an adjuvant alternative in the clinical management of hypertension. Thus, we tested the hypothesis that coconut oil supplementation, isolated or combined with physical training, could exert antihypertensive effects in patients with stage 1 hypertension.</p></sec><sec id="sec2-nutrients-13-00798"><title>2. Materials and Methods</title><sec id="sec2dot1-nutrients-13-00798"><title>2.1. Subjects and Experimental Groups</title><p>Hypertensive patients were recruited to participate in this placebo-controlled study. Patients with stage 1 systemic arterial hypertension (mild hypertension) were included. This degree of hypertension is characterized by levels of systolic blood pressure between 140 and 159 mmHg and/or diastolic blood pressure between 90 and 99 mmHg [<xref rid="B15-nutrients-13-00798" ref-type="bibr">15</xref>]. Patients were evaluated by 24-hour blood pressure monitoring to confirm the diagnosis of hypertension and for follow-up during the experimental period. The study included patients of both genders with a minimum age of 20 and a maximum age of 64 years. Patients with diabetes mellitus or under pharmacological treatment for hypertension were not included. The study was conducted in accordance with the ethical guidelines of the Declaration of Helsinki and approved by the Research Ethics Committee of the University Hospital of the Federal University of Paraiba, Brazil (protocol n&#x000ba; 1.523.128/2016). Written informed consent was obtained from all volunteers prior to participation. In addition, this clinical protocol was approved in the Brazilian Registry of Clinical Trials (n&#x000ba; RBR-5s9bhc).</p><p>The sample size was based on the outcome of reduced systolic blood pressure obtained by Perona et al. [<xref rid="B16-nutrients-13-00798" ref-type="bibr">16</xref>], considering a mean difference of 14 mmHg with a standard deviation of 10 and 8 mmHg for each group. The sample size was calculated with the open license tool at (<uri xlink:href="https://www.openepi.com">https://www.openepi.com</uri> (accessed on 1 February, 2017)) and, as a result, a minimum of seven subjects for each group was obtained, considering a confidence interval of 95% and a statistical power of 80%. Our study included 51 hypertensive patients who were allocated by simple random distribution (1:1) using a freely available website (<uri xlink:href="www.randomizer.org">www.randomizer.org</uri> (accessed on 1 February, 2017)). These patients were followed up in the experimental groups: group supplemented with extra-virgin coconut oil&#x02014;EVCO; group supplemented with placebo; group supplemented with EVCO plus physical training (EVCO-training); and group supplemented with placebo plus physical training (placebo-training). Six patients did not complete the treatment protocol and were excluded. Two of them were from the EVCO group (one on a physical training protocol and one untrained). The patient in the training group dropped out of the study, and the other patient started pharmacological treatment by decision of the cardiologist on the study team. The remaining four losses were from patients supplemented with the placebo intervention (one from the trained group and three from the untrained group). The patient in the trained group had to move from the study city, and the other three dropped out the study. Considering blood pressure analyzes, two records were excluded (one from the placebo group and one from the EVCO group) because they did not reach more than 80% of the valid measures after 24-hour monitoring. Thus, we had the following experimental groups: EVCO, <italic>n</italic> = 14; Placebo, <italic>n</italic> = 11; EVCO-training, <italic>n</italic> = 11; and Placebo-training, <italic>n</italic> = 9, <xref ref-type="fig" rid="nutrients-13-00798-f001">Figure 1</xref>.</p></sec><sec id="sec2dot2-nutrients-13-00798"><title>2.2. Study Design and Experimental Protocols</title><p>This is a randomized, single-blinded, placebo controlled clinical trial. Patients were initially submitted to 24-hour ambulatory blood pressure monitoring according to VI Brazilian guidelines for hypertension [<xref rid="B15-nutrients-13-00798" ref-type="bibr">15</xref>]. Blood collection was performed to biochemical analysis. After the initial evaluation, the patients in each group were submitted to food supplementation with EVCO capsules or placebo for a period of 30 days. Twenty-four hours after the last day of this intervention period, patients were again evaluated for initial variable.</p><p>The patients receiving EVCO or placebo were instructed to intake 10 capsules a day within the main meals as follows: three during the breakfast, four during lunch and three during dinner. The EVCO groups received 10 mL/day (1 mL in each capsule) of EVCO (<italic>Cocos nucifera</italic> L.) [<xref rid="B17-nutrients-13-00798" ref-type="bibr">17</xref>]. Both preparations were standardized in a specialized pharmacy (registration with the Ministry of Health N&#x000ba;. 5.6372.0016.001-4) (<xref rid="nutrients-13-00798-t001" ref-type="table">Table 1</xref>).</p><p>The training protocol consisted of four weeks of aerobic training (walking and/or running on an ergometric treadmill), three times per week, lasting 60 min, of moderate intensity (50% to 70% heart rate reserve) [<xref rid="B18-nutrients-13-00798" ref-type="bibr">18</xref>]. A one mile field test was performed prior to the protocol to estimate the maximum oxygen consumption and to obtain the maximum heart rate [<xref rid="B19-nutrients-13-00798" ref-type="bibr">19</xref>]. The heart rate of training was determined based on the reserve heart rate [<xref rid="B20-nutrients-13-00798" ref-type="bibr">20</xref>], monitored by Polar<sup>&#x000ae;</sup> frequency meter model M200 (Polar Electro, Kempele, Finland), and supervised by rating of perceived exertion [<xref rid="B21-nutrients-13-00798" ref-type="bibr">21</xref>].</p></sec><sec id="sec2dot3-nutrients-13-00798"><title>2.3. Nutritional Evaluation</title><p>The dietary intake of each patient was assessed by a three day food recorder, two representing the weekday diet and one representing the weekend diet. The average food consumption over the three days was used for nutritional assessment. The analysis was performed by a nutrition professional using a nutritional software (Dietwin Plus<sup>&#x000ae;</sup>, version 3048/16, Porto Alegre, Brazil). The nutritional parameters of total energy intake, carbohydrates, total proteins and fats, saturated fatty acids (including lauric acid), unsaturated fatty acids, intake of sodium and antioxidants were selected for analysis.</p></sec><sec id="sec2dot4-nutrients-13-00798"><title>2.4. Thiobarbituric Acid Reactive Substances (TBARS) Assay and Clinical Biochemistry Measurements</title><p>To evaluate lipid peroxidation, serum samples were collected to measure levels of malondialdehyde (MDA) determined by TBARS assay [<xref rid="B22-nutrients-13-00798" ref-type="bibr">22</xref>]. After blood collections, the samples were centrifuged at 5000&#x000d7; <italic>g</italic> for 10 min to obtain serum. Then, 250 &#x000b5;L of serum were stored at 37 &#x000b0;C for 1 h, after which 400 &#x000b5;L of 35% perchloric acid was added, and the mixture was centrifuged (14,000&#x000d7; <italic>g</italic>/4 &#x000b0;C) for 20 min. Four hundred and fifty microliters of supernatant was removed and mixed with 0.6% thiobarbituric acid and incubated at 90 &#x000b0;C for 1 h. Then, absorbance at 532 nm was measured. A standard curve was generated using 1,1,3,3-tetrametoxypropane. Results were expressed as nmol/mL.</p><p>Serum was used to determine total cholesterol, triglycerides, low density lipoproteins (LDL-cholesterol), high density lipoproteins (HDL-cholesterol) and glucose using colorimetric standardized commercial kits (Blioclin-Quibasa, MG, Brazil). Non-HDL-cholesterol is calculated by subtracting HDL-cholesterol from total cholesterol.</p></sec><sec id="sec2dot5-nutrients-13-00798"><title>2.5. Ambulatory Blood Pressure Monitoring [ABPM) for 24 Hours and Anthropometric Measures</title><p>The BP was measured for a period of 24 h using a Dyna MAPA + <italic>Cardios</italic><sup>&#x000ae;</sup> device (S&#x000e3;o Paulo, Brazil). The equipment was programmed to perform measurements every 15 min during the waking period and every 30 min during sleep, according to the recommendations of the 4th Guidelines for Ambulatory Blood Pressure Monitoring and 2nd Guidelines for Residential Blood Pressure Monitoring [<xref rid="B23-nutrients-13-00798" ref-type="bibr">23</xref>]. The data obtained during registration were used to determine the mean values of systolic diastolic blood pressure and mean. In addition, they were also used to establish the parameters of blood pressure variability, standard deviation and average real variability [<xref rid="B24-nutrients-13-00798" ref-type="bibr">24</xref>]. In addition, patients were weighed and measured using a portable stadiometer (1 mm accuracy) and a body weight apparatus (OMRON<sup>&#x000ae;</sup> model HBF-514C, Shiokoji Horikawa, Shimogyo-ku, Kyoto, Japan). Body mass index was calculated using the formula weight/(height)<sup>2</sup>.</p></sec><sec id="sec2dot6-nutrients-13-00798"><title>2.6. Statistical Analysis</title><p>The analysis of normality was performed by Shapiro-Wilk test. Non-normal variable (malondialdehyde) was log-transformed from their original values. In the nutritional analysis, a comparison between means of the diet components the placebo and EVCO periods was made by unpaired <italic>t</italic> Student test. For the other analyses, a one-way ANCOVA corrected by age was performed with repeated measurements, followed by Bonferroni post-test. The data were expressed as means and standard deviation and the significance level was adopted with <italic>p</italic> &#x0003c; 0.05. The effect size values were expressed by the partial <italic>eta</italic> square (<italic>&#x003b7;</italic><sup>2</sup>).</p></sec></sec><sec sec-type="results" id="sec3-nutrients-13-00798"><title>3. Results</title><sec id="sec3dot1-nutrients-13-00798" sec-type="subjects"><title>3.1. Baseline Profile of Participants</title><p><xref rid="nutrients-13-00798-t002" ref-type="table">Table 2</xref> displays the baseline assessment of the patients treated in this study. The patients showed body mass index (BMI) in the overweight range and total cholesterol, triglycerides and non-HDL cholesterol with borderline concentrations.</p></sec><sec id="sec3dot2-nutrients-13-00798"><title>3.2. Nutritional Analysis of Food Records</title><p>The records obtained from the food diaries of the patients supplemented with coconut oil or placebo indicates that there was no difference in the energy intake (1961 (1700&#x02013;2222) vs. 1678 (1450&#x02013;1905) kcal; <italic>p</italic> = 0.134), carbohydrate intake (252.8 (200.1&#x02013;305.5) vs. 213.2 (177.9&#x02013;248.4) g; <italic>p</italic> = 0.278) and total fats intake (69.1 (56.7&#x02013;81.5) vs. 55.7 (40.5&#x02013;70.8) g; <italic>p</italic> = 0.161). However, considering the fractions of saturated fats (29.3 (23.5&#x02013;35.1) vs. 18.5 (12.0&#x02013;24.8) g; <italic>p</italic> = 0.017) and the amount of lauric acid (4.64 (4.50&#x02013;4.77) vs. 0.20 (0.07&#x02013;0.34) g; <italic>p</italic>&#x0003c;0.001) ingested in periods of coconut oil and placebo supplementation, respectively, a greater amount of saturated fats and lauric acid is observed for patients supplemented with coconut oil. For the other dietary constituents evaluated (proteins, cholesterol, linolenic acid, trans fats, sodium, zinc, vitamins B12, B9, A, C, E and &#x003b2;-carotene) there was no significant difference between the periods of supplementation with EVCO and placebo (data not shown). In addition, no adverse effects (diarrhea, constipation, nausea, colic, migraine, among others) were observed or reported in relation to the use of 10 mL/day of EVCO during the 30-day period, suggesting that this pattern of dietary supplementation is fully safe in humans.</p></sec><sec id="sec3dot3-nutrients-13-00798"><title>3.3. Analysis of 24-Hour Blood Pressure Monitoring</title><p><xref ref-type="fig" rid="nutrients-13-00798-f002">Figure 2</xref> shows the mean blood pressure values obtained from the 24-hour blood pressure record of hypertensive patients, before and after the 30-day intervention for all experimental groups. No differences were found.</p></sec><sec id="sec3dot4-nutrients-13-00798"><title>3.4. Analysis of Serum Concentrations of Malondialdehyde</title><p>There is no EVCO-induced effect on serum MDA concentrations (nmol/mL) assessed after the experimental intervention compared to control intervention (EVCO (2.22 &#x000b1; 0.10 vs. 2.24 &#x000b1; 0.13); Placebo (2.27 &#x000b1; 0.11 vs. 2.32 &#x000b1; 0.15); EVCO <italic>plus</italic> training (2. 63 &#x000b1; 0.10 vs. 2.20 &#x000b1; 0.14); and Placebo <italic>plus</italic> training (2.21 &#x000b1; 0.12 vs. 2.29 &#x000b1; 0.17); <italic>p</italic> = 0.644 and <italic>&#x003b7;</italic><sup>2</sup> = 0.009). However, there is an interaction effect between time and group that appears to be promoted as a function of a decrease between initial and final MDA concentrations among patients who were supplemented with EVCO and trained (<italic>p</italic> = 0.015 and <italic>&#x003b7;</italic><sup>2</sup> = 0.227) (<xref ref-type="fig" rid="nutrients-13-00798-f003">Figure 3</xref>).</p></sec><sec id="sec3dot5-nutrients-13-00798"><title>3.5. Analysis of Blood Pressure Variability</title><p>The analysis of blood pressure variability data, represented by standard deviation (SD) and average real variability (ARV), showed that supplementation with EVCO was not effective within the assessed groups: SD&#x02013;MAP: (EVCO (9.27 &#x000b1; 0.54 vs. 8.73 &#x000b1; 0.510); Placebo (8.90 &#x000b1; 0.65 vs. 9.60 &#x000b1; 0.60); EVCO <italic>plus</italic> training (10.2 &#x000b1; 0.57 vs. 9.58 &#x000b1; 0.53) and Placebo <italic>plus</italic> training (9.40 &#x000b1; 0.64 vs. 9.56 &#x000b1; 0.60)); and ARV&#x02013;MAP: (EVCO (6.39 &#x000b1; 0.33 vs. 5.80 &#x000b1; 0.28; Placebo (6.22 &#x000b1; 0.40 vs. 6.50 &#x000b1; 0.34); EVCO <italic>plus</italic> training (6.57 &#x000b1; 0.34 vs. 6.07 &#x000b1; 0.29); and Placebo <italic>plus</italic> training (6.37 &#x000b1; 0.40 vs. 6.71 &#x000b1; 0.33)) (<xref ref-type="fig" rid="nutrients-13-00798-f004">Figure 4</xref>).</p></sec></sec><sec sec-type="discussion" id="sec4-nutrients-13-00798"><title>4. Discussion</title><p>Original preclinical studies provided evidence that both <italic>in natura</italic> coconut oil and its main isolated constituent, lauric acid, were able to evoke antihypertensive effect in spontaneously hypertensive rats and vasorelaxant effect in superior mesenteric artery, respectively [<xref rid="B13-nutrients-13-00798" ref-type="bibr">13</xref>,<xref rid="B14-nutrients-13-00798" ref-type="bibr">14</xref>]. It was also shown that these effects could be related to a reduction in oxidative stress in these experimental models. However, from a translational perspective, no study has been conducted to assess the possible effects of coconut oil in humans with hypertension.</p><p>Clinical studies with specific subpopulations and testing non-pharmacological alternatives are essential. Thus, considering the preliminary research, this was the first trial designed to assess the effects of EVCO in patients with systemic arterial hypertension. So, this study represents an effort to test an unknown outcome on the use of coconut oil in humans. In addition, we highlight the fact that the present study controlled precisely (through supplementation with capsules) the amount of EVCO effectively ingested. An important proportion of the studies that focus on this natural product did not properly control the amount of EVCO ingested; instead, it was included in meal preparation, without precise delimitations of its consumption [<xref rid="B25-nutrients-13-00798" ref-type="bibr">25</xref>,<xref rid="B26-nutrients-13-00798" ref-type="bibr">26</xref>]. Our study was placebo-controlled and used a biologically inert substance as a control intervention, the pharmaceutical starch. This is relevant because several studies have compared the use of coconut oil with other vegetable oils, which sometimes also have biological effects, causing complications in the interpretation of the results obtained [<xref rid="B27-nutrients-13-00798" ref-type="bibr">27</xref>,<xref rid="B28-nutrients-13-00798" ref-type="bibr">28</xref>].</p><p>Regarding the primarily investigated outcome, there was no antihypertensive effect associated with supplementation with EVCO in patients with stage 1 arterial hypertension tested in this study, unlike what was evidenced in the preclinical study with an animal model of essential hypertension [<xref rid="B13-nutrients-13-00798" ref-type="bibr">13</xref>]. Clinically, it should be noted that the diagnostic parameter used in this study was consistent, since a 24-hour blood pressure monitoring technique was used. The ABPM is fundamental in the evaluation of the efficacy of antihypertensive drugs in clinical trials and, consequently, very useful in the clinical management of hypertension [<xref rid="B29-nutrients-13-00798" ref-type="bibr">29</xref>]. This type of cardiological evaluation has a high diagnostic power [<xref rid="B30-nutrients-13-00798" ref-type="bibr">30</xref>], as it eliminates stress-induced momentary hypertension, called white coat hypertension. Sometimes, an isolated outpatient measure may not reflect the patient&#x02019;s real blood pressure [<xref rid="B31-nutrients-13-00798" ref-type="bibr">31</xref>]. In some cases, a sympathetic discharge associated with the situation of being evaluated by a cardiologist is sufficient to induce a pressure response [<xref rid="B32-nutrients-13-00798" ref-type="bibr">32</xref>]. This evidence reinforces caution in issuing false-positive results. Finally, this monitoring reflects the pressure behavior during the entire 24 h period. On average, approximately 70 (seventy) blood pressure measurements are performed, without interference from the human factor during the checks, minimizing the measurement bias.</p><p>With regards to the difference in response evoked by coconut oil supplementation between pre-clinical and clinical studies, it is prudent to consider the distinctions inherent to each experimental model that was used in each study. The two studies involve specimens with different structure and metabolism and also with different experimental conditions. In the preclinical study, the dose of coconut oil administered was 2 mL per day for animals weighing between 200&#x02013;300 g. Based on this dosage, if this was extrapolated for use in adult humans (average weight 70 Kg), an amount that would exceed 500 mL of EVCO per day would be necessary [<xref rid="B33-nutrients-13-00798" ref-type="bibr">33</xref>]. The dose used in this study (10 mL/day) was based on the study by [<xref rid="B17-nutrients-13-00798" ref-type="bibr">17</xref>] which proved to be safe, with no adverse effects recorded. [<xref rid="B34-nutrients-13-00798" ref-type="bibr">34</xref>] demonstrated that virgin coconut oil (1.4 mL/kg weight) prevents blood pressure elevation in rats fed palm oil. The experiment used 32 male Sprague-Dawley rats and measurements were performed every four weeks for a total period of 16 weeks by tail-cuff method. It is not clear that the beneficial effects attributed to coconut oil obtained in animal studies can be extended to humans. For example, Khaw et al. [<xref rid="B28-nutrients-13-00798" ref-type="bibr">28</xref>] compared three types of diets: EVCO, extravirgin olive oil and unsalted butter. The participants incorporated 50 g of the respective fats into their usual diet for a period of four weeks. These authors did not report any difference in pressure levels after the experimental period. On the other hand, Perona et al. [<xref rid="B16-nutrients-13-00798" ref-type="bibr">16</xref>] observed a reduction in systolic blood pressure levels in elderly hypertensive patients after using 60 g/day virgin olive oil for four weeks. Indeed, unlike what is observed in relation to coconut oil, Massaro et al. [<xref rid="B35-nutrients-13-00798" ref-type="bibr">35</xref>], through a distinguished review work, showed that there is relative similarity of effects between pre-clinical and clinical studies addressing the use of olive oil to treat hypertension. Summarizing, Wallace [<xref rid="B25-nutrients-13-00798" ref-type="bibr">25</xref>] performed a systematic review on the effects of coconut oil and concluded that the available evidence is sufficient only to encourage new studies with more methodological robustness. Another important aspect that deserves consideration is that, in order to avoid the confounding effects of medication, we opted for stage 1 hypertensive patients. Whether coconut oil may exert some beneficial effect on blood pressure of patients with higher blood pressure levels remains to be elucidated.</p><p>Although no effect on blood pressure was observed, a possible effect of EVCO on the autonomic function of patients was investigated. Two main factors motivated this experimental approach. First, in the pre-clinical study it was seen that, besides the antihypertensive activity, the supplementation with EVCO was associated with a reduction in oxidative stress and with an improvement in the baroreflex response in the treated animals [<xref rid="B13-nutrients-13-00798" ref-type="bibr">13</xref>]. Second, this interrelationship between a disturbance of blood pressure control mechanisms and the development of hypertension is widely reported [<xref rid="B36-nutrients-13-00798" ref-type="bibr">36</xref>]. A reduction in the effectiveness of control mechanisms can be expressed by increases in blood pressure oscillations over time [<xref rid="B37-nutrients-13-00798" ref-type="bibr">37</xref>]. It is important to emphasize that the autonomic function can also be explored through the analysis of blood pressure variability. This alternative constitutes a non-invasive tool capable of providing parameters related to autonomic activity based on blood pressure oscillations over time [<xref rid="B38-nutrients-13-00798" ref-type="bibr">38</xref>].</p><p>Blood pressure variability is not a physiological variable routinely accessed in clinical practice, although according to Hsu et al. [<xref rid="B39-nutrients-13-00798" ref-type="bibr">39</xref>], it is recognized as a prognostic factor independent of blood pressure level [<xref rid="B24-nutrients-13-00798" ref-type="bibr">24</xref>]. Evidence shows that the adverse cardiovascular consequences of high blood pressure may be the result of increased variability and not high blood pressure alone [<xref rid="B40-nutrients-13-00798" ref-type="bibr">40</xref>,<xref rid="B41-nutrients-13-00798" ref-type="bibr">41</xref>]. In addition, there is a strong association between increased BP variability and subclinical progression of target organ damage [<xref rid="B42-nutrients-13-00798" ref-type="bibr">42</xref>]. Two indexes of BP variability were used, the standard deviation and the average real variability. They are not redundant analyses, because according to Mena [<xref rid="B24-nutrients-13-00798" ref-type="bibr">24</xref>], ARV offers an additional reinforcement in the variability representation. Our results indicated no effect of ECVO supplementation on the variability indices evaluated. Furthermore, no effect interaction between the groups was observed, although a moderate effect size persists considering the average real variability. The analysis indicates that physical training did not prove to be determinant for this response. Although aerobic exercise is a useful complement to control hypertension, it does not necessarily affect blood pressure variability [<xref rid="B43-nutrients-13-00798" ref-type="bibr">43</xref>]. In addition, the most effective training protocols for lowering blood pressure levels are longer (minimum 8&#x02013;12 weeks) [<xref rid="B44-nutrients-13-00798" ref-type="bibr">44</xref>]. The associative effect, i.e., the potentiating effect promoted by the supplementation with EVCO in combination with training, seen in the pre-clinical study [<xref rid="B13-nutrients-13-00798" ref-type="bibr">13</xref>], has not been fully reproduced in humans.</p><p>In addition, through the antioxidant potential of several coconut oil constituents [<xref rid="B45-nutrients-13-00798" ref-type="bibr">45</xref>,<xref rid="B46-nutrients-13-00798" ref-type="bibr">46</xref>] and the relationship between reactive oxygen species and hypertension control mechanisms [<xref rid="B47-nutrients-13-00798" ref-type="bibr">47</xref>,<xref rid="B48-nutrients-13-00798" ref-type="bibr">48</xref>] analyses were conducted to estimate the serum oxidative stress of hypertensive patients. This effect was evaluated by comparing the serum concentrations of MDA, a byproduct of lipid peroxidation, in different experimental conditions. As previously mentioned, this interaction between oxidative stress and damage to the autonomic function is well documented [<xref rid="B49-nutrients-13-00798" ref-type="bibr">49</xref>,<xref rid="B50-nutrients-13-00798" ref-type="bibr">50</xref>] and increase in the variability has been linked to alterations in autonomic function, including sympathetic hyperactivity [<xref rid="B51-nutrients-13-00798" ref-type="bibr">51</xref>]. Following the findings of ineffectiveness obtained on the cardiovascular variables of blood pressure and blood pressure variability, it was found that nutritional supplementation with EVCO was not able to interfere with the oxidative stress accessed through the MDA. Only an isolated effect of the interaction was seen in the group supplemented with EVCO which also participated in the physical training program. Although this effect reproduces, at least in part, the possible amplifying response of EVCO combined with exercise training, it was obtained in a group that started from a higher baseline value of MDA.</p><p>In fact, the effectiveness of this antioxidant property inherent to EVCO has been attributed almost exclusively to animal models. Nevin and Ramajohan [<xref rid="B9-nutrients-13-00798" ref-type="bibr">9</xref>] showed that virgin coconut oil was related to an increase in the activity of the enzymes glutathione peroxidase, catalase and superoxide dismutase in organs such as liver, heart and kidneys. Famurewa et al. [<xref rid="B8-nutrients-13-00798" ref-type="bibr">8</xref>] demonstrated that this increase in the activity of hepatic catalase and superoxide dismutase (but not GPx) occurred in a concentration dependent on EVCO and that they were related to a decrease in MDA. This response was also observed in homogenate of rat heart muscle [<xref rid="B10-nutrients-13-00798" ref-type="bibr">10</xref>]. Studies in humans focusing on the antioxidant property of coconut oil are rare and less consistent. Sabitha et al. [<xref rid="B52-nutrients-13-00798" ref-type="bibr">52</xref>], for example, found no significant differences between individuals treated with coconut or sunflower oil in relation to oxidative stress. Additionally, the results indicated that physical exercise was not able to promote significant changes in oxidative stress after 30 days. It seems that this relationship between exercise and oxidative stress is complicated and can be modulated in several levels of intensity, type and duration of training [<xref rid="B53-nutrients-13-00798" ref-type="bibr">53</xref>,<xref rid="B54-nutrients-13-00798" ref-type="bibr">54</xref>]. Regarding other possible sources of exogenous antioxidants offered by the diet during the experimental period that could eventually have interfered with the responses discussed in this study, it should be noted that the nutritional follow-up implemented represented an additional factor to reinforce the evidence presented.</p><p>In conclusion, the supplementation with EVCO did not have an antihypertensive effect in patients with stage 1 hypertension. It also showed no effectiveness on blood pressure variability and oxidative stress levels in humans. Thus, although coconut oil supplementation (10 mL/day) was shown to be safe as a nutritional approach and without significant impacts on the caloric load intake, it was not able to reproduce the effects obtained in an experimental model of hypertension when translated to hypertensive patients. Finally, it should be ratified that complementary studies are necessary to determine if doses different from the current trial can evoke additional or diverse effects.</p></sec></body><back><ack><title>Acknowledgments</title><p>Authors want to thank Jos&#x000e9; Cazuza F J&#x000fa;nior for the support in statistics and additional thanks to Alex A. Ara&#x000fa;jo for the help in the tabulation for the analysis of blood pressure variability.</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>V.A.B. conceived the study. F.A.O.J. and C.R.R. performed the experiments. Y.d.O. reviewed the nutritional records. M.A.V.B. performed cardiologic consultations. A.S.S. contributed to the physical training program. M.S.B.S. enabled the analysis of blood pressure variability. V.J.B.M. contributed in the statistical analysis. C.M.B. and F.A.O.J. drafted the manuscript. All authors analyzed the data and revised the manuscript critically. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research was funded by the National Council for the Development of Science and Technology (CNPq, 429767/2016-1 and 304718/2011-4) and by the Paraiba State Research Foundation (FAPESQ, ID: 007/2019 FAPESQ-PB-MCT/CNPq).</p></notes><notes><title>Institutional Review Board Statement</title><p>The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of the University Hospital at the Federal University of Paraiba (protocol code 1.523.128/2016 approved on 04/30/2016). Informed consent was obtained from all subjects involved in the study. All data regarding this study are available upon request to the corresponding author by the e-mail: <email>valdir@cbiotec.ufpb.br</email>.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-nutrients-13-00798"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamin</surname><given-names>E.J.</given-names></name><name><surname>Virani</surname><given-names>S.S.</given-names></name><name><surname>Callaway</surname><given-names>C.W.</given-names></name><name><surname>Chamberlain</surname><given-names>A.M.</given-names></name><name><surname>Chang</surname><given-names>A.R.</given-names></name><name><surname>Cheng</surname><given-names>S.</given-names></name><name><surname>Chiuve</surname><given-names>S.E.</given-names></name><name><surname>Cushman</surname><given-names>M.</given-names></name><name><surname>Delling</surname><given-names>F.N.</given-names></name><name><surname>Deo</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Heart Disease and Stroke Statistics-2018 Update: A Report from the American Heart Association</article-title><source>Circulation</source><year>2018</year><volume>137</volume><fpage>e67</fpage><lpage>e492</lpage><pub-id pub-id-type="doi">10.1161/CIR.0000000000000558</pub-id><pub-id pub-id-type="pmid">29386200</pub-id></element-citation></ref><ref id="B2-nutrients-13-00798"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittal</surname><given-names>B.V.</given-names></name><name><surname>Singh</surname><given-names>A.K.</given-names></name></person-group><article-title>Hypertension in the developing world: Challenges and opportunities</article-title><source>Am. J. Kidney Dis.</source><year>2010</year><volume>55</volume><fpage>590</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2009.06.044</pub-id><?supplied-pmid 19962803?><pub-id pub-id-type="pmid">19962803</pub-id></element-citation></ref><ref id="B3-nutrients-13-00798"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massa</surname><given-names>N.M.</given-names></name><name><surname>Silva</surname><given-names>A.S.</given-names></name><name><surname>Toscano</surname><given-names>L.T.</given-names></name><name><surname>Silva</surname><given-names>J.D.</given-names></name><name><surname>Persuhn</surname><given-names>D.C.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>M.A.C.</given-names></name></person-group><article-title>Watermelon extract reduces blood pressure but does not change sympathovagal balance in prehypertensive and hypertensive subjects</article-title><source>Blood Press.</source><year>2016</year><volume>25</volume><fpage>244</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.3109/08037051.2016.1150561</pub-id><pub-id pub-id-type="pmid">26947668</pub-id></element-citation></ref><ref id="B4-nutrients-13-00798"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toscano</surname><given-names>L.T.</given-names></name><name><surname>da Silva</surname><given-names>C.S.</given-names></name><name><surname>de Almeida</surname><given-names>A.E.</given-names></name><name><surname>Santos</surname><given-names>A.a.C.</given-names></name><name><surname>Silva</surname><given-names>A.S.</given-names></name></person-group><article-title>Chia flour supplementation reduces blood pressure in hypertensive subjects</article-title><source>Plant Foods Hum. Nutr.</source><year>2014</year><volume>69</volume><fpage>392</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1007/s11130-014-0452-7</pub-id><?supplied-pmid 25403867?><pub-id pub-id-type="pmid">25403867</pub-id></element-citation></ref><ref id="B5-nutrients-13-00798"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devarajan</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Chatterjee</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Ali</surname><given-names>A.</given-names></name></person-group><article-title>A blend of sesame oil and rice bran oil lowers blood pressure and improves the lipid profile in mild-to-moderate hypertensive patients</article-title><source>J. Clin. Lipidol.</source><year>2016</year><volume>10</volume><fpage>339</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1016/j.jacl.2015.12.011</pub-id><pub-id pub-id-type="pmid">27055965</pub-id></element-citation></ref><ref id="B6-nutrients-13-00798"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DebMandal</surname><given-names>M.</given-names></name><name><surname>Mandal</surname><given-names>S.</given-names></name></person-group><article-title>Coconut (<italic>Cocos nucifera</italic> L.: Arecaceae): In health promotion and disease prevention</article-title><source>Asian Pac. J. Trop. Med.</source><year>2011</year><volume>4</volume><fpage>241</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/S1995-7645(11)60078-3</pub-id><pub-id pub-id-type="pmid">21771462</pub-id></element-citation></ref><ref id="B7-nutrients-13-00798"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chinwong</surname><given-names>S.</given-names></name><name><surname>Chinwong</surname><given-names>D.</given-names></name><name><surname>Mangklabruks</surname><given-names>A.</given-names></name></person-group><article-title>Daily Consumption of Virgin Coconut Oil Increases High-Density Lipoprotein Cholesterol Levels in Healthy Volunteers: A Randomized Crossover Trial</article-title><source>Evid. Based Complement. Alternat. Med.</source><year>2017</year><volume>2017</volume><fpage>7251562</fpage><pub-id pub-id-type="doi">10.1155/2017/7251562</pub-id><?supplied-pmid 29387131?><pub-id pub-id-type="pmid">29387131</pub-id></element-citation></ref><ref id="B8-nutrients-13-00798"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Famurewa</surname><given-names>A.C.</given-names></name><name><surname>Ekeleme-Egedigwe</surname><given-names>C.A.</given-names></name><name><surname>Nwali</surname><given-names>S.C.</given-names></name><name><surname>Agbo</surname><given-names>N.N.</given-names></name><name><surname>Obi</surname><given-names>J.N.</given-names></name><name><surname>Ezechukwu</surname><given-names>G.C.</given-names></name></person-group><article-title>Dietary Supplementation with Virgin Coconut Oil Improves Lipid Profile and Hepatic Antioxidant Status and Has Potential Benefits on Cardiovascular Risk Indices in Normal Rats</article-title><source>J. Diet. Suppl.</source><year>2018</year><volume>15</volume><fpage>330</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1080/19390211.2017.1346031</pub-id><pub-id pub-id-type="pmid">28816548</pub-id></element-citation></ref><ref id="B9-nutrients-13-00798"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nevin</surname><given-names>K.G.</given-names></name><name><surname>Rajamohan</surname><given-names>T.</given-names></name></person-group><article-title>Virgin coconut oil supplemented diet increases the antioxidant status in rats</article-title><source>Food Chem.</source><year>2006</year><pub-id pub-id-type="doi">10.1016/j.foodchem.2005.06.056</pub-id></element-citation></ref><ref id="B10-nutrients-13-00798"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subermaniam</surname><given-names>K.</given-names></name><name><surname>Saad</surname><given-names>Q.H.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Othman</surname><given-names>F.</given-names></name></person-group><article-title>Virgin Coconut Oil (VCO) Decreases the Level of Malondialdehyde (MDA) in the Cardiac Tissue of Experimental Sprague-Dawley Rats Fed with Heated Palm O | Request PDF</article-title><source>J. Med. Bioeng.</source><year>2014</year><volume>3</volume><pub-id pub-id-type="doi">10.12720/jomb.3.2.102-106</pub-id></element-citation></ref><ref id="B11-nutrients-13-00798"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eyres</surname><given-names>L.</given-names></name><name><surname>Eyres</surname><given-names>M.F.</given-names></name><name><surname>Chisholm</surname><given-names>A.</given-names></name><name><surname>Brown</surname><given-names>R.C.</given-names></name></person-group><article-title>Coconut oil consumption and cardiovascular risk factors in humans</article-title><source>Nutr. Rev.</source><year>2016</year><volume>74</volume><fpage>267</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1093/nutrit/nuw002</pub-id><pub-id pub-id-type="pmid">26946252</pub-id></element-citation></ref><ref id="B12-nutrients-13-00798"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacks</surname><given-names>F.M.</given-names></name></person-group><article-title>Coconut Oil and Heart Health: Fact or Fiction?</article-title><source>Circulation</source><year>2020</year><volume>141</volume><fpage>815</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.119.044687</pub-id><?supplied-pmid 31928069?><pub-id pub-id-type="pmid">31928069</pub-id></element-citation></ref><ref id="B13-nutrients-13-00798"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alves</surname><given-names>N.F.</given-names></name><name><surname>Porpino</surname><given-names>S.K.</given-names></name><name><surname>Monteiro</surname><given-names>M.M.</given-names></name><name><surname>Gomes</surname><given-names>E.R.</given-names></name><name><surname>Braga</surname><given-names>V.A.</given-names></name></person-group><article-title>Coconut oil supplementation and physical exercise improves baroreflex sensitivity and oxidative stress in hypertensive rats</article-title><source>Appl. Physiol. Nutr. Metab.</source><year>2015</year><volume>40</volume><fpage>393</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1139/apnm-2014-0351</pub-id><pub-id pub-id-type="pmid">25659569</pub-id></element-citation></ref><ref id="B14-nutrients-13-00798"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alves</surname><given-names>N.F.</given-names></name><name><surname>de Queiroz</surname><given-names>T.M.</given-names></name><name><surname>de Almeida Travassos</surname><given-names>R.</given-names></name><name><surname>Magnani</surname><given-names>M.</given-names></name><name><surname>de Andrade Braga</surname><given-names>V.</given-names></name></person-group><article-title>Acute Treatment with Lauric Acid Reduces Blood Pressure and Oxidative Stress in Spontaneously Hypertensive Rats</article-title><source>Basic Clin. Pharmacol. Toxicol.</source><year>2017</year><volume>120</volume><fpage>348</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1111/bcpt.12700</pub-id><pub-id pub-id-type="pmid">28054477</pub-id></element-citation></ref><ref id="B15-nutrients-13-00798"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malachias</surname><given-names>M.V.</given-names></name></person-group><article-title>7th Brazilian Guideline of Arterial Hypertension: Presentation</article-title><source>Arq. Bras. Cardiol.</source><year>2016</year><volume>107</volume><fpage>XV&#x02013;XIX</fpage><pub-id pub-id-type="doi">10.5935/abc.20160140</pub-id></element-citation></ref><ref id="B16-nutrients-13-00798"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perona</surname><given-names>J.S.</given-names></name><name><surname>Canizares</surname><given-names>J.</given-names></name><name><surname>Montero</surname><given-names>E.</given-names></name><name><surname>Sanchez-Dominguez</surname><given-names>J.M.</given-names></name><name><surname>Catala</surname><given-names>A.</given-names></name><name><surname>Ruiz-Gutierrez</surname><given-names>V.</given-names></name></person-group><article-title>Virgin olive oil reduces blood pressure in hypertensive elderly subjects</article-title><source>Clin. Nutr.</source><year>2004</year><volume>23</volume><fpage>1113</fpage><lpage>1121</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2004.02.004</pub-id><?supplied-pmid 15380903?><pub-id pub-id-type="pmid">15380903</pub-id></element-citation></ref><ref id="B17-nutrients-13-00798"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>K.S.</given-names></name><name><surname>Azman</surname><given-names>N.</given-names></name><name><surname>Omar</surname><given-names>E.A.</given-names></name><name><surname>Musa</surname><given-names>M.Y.</given-names></name><name><surname>Yusoff</surname><given-names>N.M.</given-names></name><name><surname>Sulaiman</surname><given-names>S.A.</given-names></name><name><surname>Hussain</surname><given-names>N.H.</given-names></name></person-group><article-title>The effects of virgin coconut oil (VCO) as supplementation on quality of life (QOL) among breast cancer patients</article-title><source>Lipids Health Dis.</source><year>2014</year><volume>13</volume><fpage>139</fpage><pub-id pub-id-type="doi">10.1186/1476-511X-13-139</pub-id><?supplied-pmid 25163649?><pub-id pub-id-type="pmid">25163649</pub-id></element-citation></ref><ref id="B18-nutrients-13-00798"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pescatello</surname><given-names>L.S.</given-names></name><name><surname>MacDonald</surname><given-names>H.V.</given-names></name><name><surname>Lamberti</surname><given-names>L.</given-names></name><name><surname>Johnson</surname><given-names>B.T.</given-names></name></person-group><article-title>Exercise for Hypertension: A Prescription Update Integrating Existing Recommendations with Emerging Research</article-title><source>Curr. Hypertens. Rep.</source><year>2015</year><volume>17</volume><fpage>87</fpage><pub-id pub-id-type="doi">10.1007/s11906-015-0600-y</pub-id><pub-id pub-id-type="pmid">26423529</pub-id></element-citation></ref><ref id="B19-nutrients-13-00798"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>George</surname><given-names>J.D.</given-names></name><name><surname>Vehrs</surname><given-names>P.R.</given-names></name><name><surname>Allsen</surname><given-names>P.E.</given-names></name><name><surname>Fellingham</surname><given-names>G.W.</given-names></name><name><surname>Fisher</surname><given-names>A.G.</given-names></name></person-group><article-title>VO2max estimation from a submaximal 1-mile track jog for fit college-age individuals</article-title><source>Med. Sci. Sports Exerc.</source><year>1993</year><volume>25</volume><fpage>401</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1249/00005768-199303000-00017</pub-id><pub-id pub-id-type="pmid">8455458</pub-id></element-citation></ref><ref id="B20-nutrients-13-00798"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karvonen</surname><given-names>M.J.</given-names></name></person-group><article-title>The effects of training on heart rate: A longitudinal study</article-title><source>Ann. Med. Exp. Biol. Fenn.</source><year>1957</year><volume>35</volume><fpage>307</fpage><lpage>315</lpage><?supplied-pmid 13470504?><pub-id pub-id-type="pmid">13470504</pub-id></element-citation></ref><ref id="B21-nutrients-13-00798"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borg</surname><given-names>G.A.</given-names></name></person-group><article-title>Perceived exertion</article-title><source>Exerc. Sport Sci. Rev.</source><year>1974</year><volume>2</volume><fpage>131</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1249/00003677-197400020-00006</pub-id><?supplied-pmid 4466663?><pub-id pub-id-type="pmid">4466663</pub-id></element-citation></ref><ref id="B22-nutrients-13-00798"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohkawa</surname><given-names>H.</given-names></name><name><surname>Ohishi</surname><given-names>N.</given-names></name><name><surname>Yagi</surname><given-names>K.</given-names></name></person-group><article-title>Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction</article-title><source>Anal. Biochem.</source><year>1979</year><volume>95</volume><fpage>351</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(79)90738-3</pub-id><pub-id pub-id-type="pmid">36810</pub-id></element-citation></ref><ref id="B23-nutrients-13-00798"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alessi</surname><given-names>A.</given-names></name><name><surname>Brand&#x000e3;o</surname><given-names>A.A.</given-names></name><name><surname>Pierin</surname><given-names>&#x000c2;.</given-names></name><name><surname>Feitosa</surname><given-names>A.M.</given-names></name><name><surname>Machado</surname><given-names>C.A.</given-names></name><name><surname>Forjaz</surname><given-names>C.L.</given-names></name><name><surname>Atie</surname><given-names>C.S.</given-names></name><name><surname>Giorgi</surname><given-names>D.M.A.</given-names></name><name><surname>Mion</surname><given-names>D.</given-names><suffix>Jr.</suffix></name><name><surname>Rosa</surname><given-names>E.C.</given-names></name></person-group><article-title>IV Guideline for Ambulatory Blood Pressure Monitoring-II Guideline for Home Blood Pressure Monitoring IV ABPM/II HBPM</article-title><source>Arq. Bras. Cardiol.</source><year>2005</year><volume>85</volume><fpage>1</fpage><lpage>18</lpage></element-citation></ref><ref id="B24-nutrients-13-00798"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mena</surname><given-names>L.J.</given-names></name><name><surname>Felix</surname><given-names>V.G.</given-names></name><name><surname>Melgarejo</surname><given-names>J.D.</given-names></name><name><surname>Maestre</surname><given-names>G.E.</given-names></name></person-group><article-title>24-Hour Blood Pressure Variability Assessed by Average Real Variability: A Systematic Review and Meta-Analysis</article-title><source>J. Am. Heart Assoc.</source><year>2017</year><volume>6</volume><fpage>e006895</fpage><pub-id pub-id-type="doi">10.1161/JAHA.117.006895</pub-id><?supplied-pmid 29051214?><pub-id pub-id-type="pmid">29051214</pub-id></element-citation></ref><ref id="B25-nutrients-13-00798"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>T.C.</given-names></name></person-group><article-title>Health Effects of Coconut Oil-A Narrative Review of Current Evidence</article-title><source>J. Am. Coll. Nutr.</source><year>2019</year><volume>38</volume><fpage>97</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1080/07315724.2018.1497562</pub-id><?supplied-pmid 30395784?><pub-id pub-id-type="pmid">30395784</pub-id></element-citation></ref><ref id="B26-nutrients-13-00798"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assun&#x000e7;&#x000e3;o</surname><given-names>M.L.</given-names></name><name><surname>Ferreira</surname><given-names>H.S.</given-names></name><name><surname>dos Santos</surname><given-names>A.F.</given-names></name><name><surname>Cabral</surname><given-names>C.R.</given-names></name><name><surname>Flor&#x000ea;ncio</surname><given-names>T.M.</given-names></name></person-group><article-title>Effects of dietary coconut oil on the biochemical and anthropometric profiles of women presenting abdominal obesity</article-title><source>Lipids</source><year>2009</year><volume>44</volume><fpage>593</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1007/s11745-009-3306-6</pub-id><pub-id pub-id-type="pmid">19437058</pub-id></element-citation></ref><ref id="B27-nutrients-13-00798"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palazhy</surname><given-names>S.</given-names></name><name><surname>Kamath</surname><given-names>P.</given-names></name><name><surname>Vasudevan</surname><given-names>D.M.</given-names></name></person-group><article-title>Dietary Fats and Oxidative Stress: A Cross-Sectional Study Among Coronary Artery Disease Subjects Consuming Coconut Oil/Sunflower Oil</article-title><source>Indian J. Clin. Biochem.</source><year>2018</year><volume>33</volume><fpage>69</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1007/s12291-017-0639-4</pub-id><?supplied-pmid 29371772?><pub-id pub-id-type="pmid">29371772</pub-id></element-citation></ref><ref id="B28-nutrients-13-00798"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khaw</surname><given-names>K.T.</given-names></name><name><surname>Sharp</surname><given-names>S.J.</given-names></name><name><surname>Finikarides</surname><given-names>L.</given-names></name><name><surname>Afzal</surname><given-names>I.</given-names></name><name><surname>Lentjes</surname><given-names>M.</given-names></name><name><surname>Luben</surname><given-names>R.</given-names></name><name><surname>Forouhi</surname><given-names>N.G.</given-names></name></person-group><article-title>Randomised trial of coconut oil, olive oil or butter on blood lipids and other cardiovascular risk factors in healthy men and women</article-title><source>BMJ Open</source><year>2018</year><volume>8</volume><fpage>e020167</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2017-020167</pub-id><?supplied-pmid 29511019?><pub-id pub-id-type="pmid">29511019</pub-id></element-citation></ref><ref id="B29-nutrients-13-00798"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancia</surname><given-names>G.</given-names></name><name><surname>Fagard</surname><given-names>R.</given-names></name><name><surname>Narkiewicz</surname><given-names>K.</given-names></name><name><surname>Red&#x000f3;n</surname><given-names>J.</given-names></name><name><surname>Zanchetti</surname><given-names>A.</given-names></name><name><surname>B&#x000f6;hm</surname><given-names>M.</given-names></name><name><surname>Christiaens</surname><given-names>T.</given-names></name><name><surname>Cifkova</surname><given-names>R.</given-names></name><name><surname>De Backer</surname><given-names>G.</given-names></name><name><surname>Dominiczak</surname><given-names>A.</given-names></name><etal/></person-group><article-title>2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)</article-title><source>J. Hypertens.</source><year>2013</year><volume>31</volume><fpage>1281</fpage><lpage>1357</lpage><pub-id pub-id-type="doi">10.1097/01.hjh.0000431740.32696.cc</pub-id><pub-id pub-id-type="pmid">23817082</pub-id></element-citation></ref><ref id="B30-nutrients-13-00798"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghazi</surname><given-names>L.</given-names></name><name><surname>Pajewski</surname><given-names>N.M.</given-names></name><name><surname>Rifkin</surname><given-names>D.E.</given-names></name><name><surname>Bates</surname><given-names>J.T.</given-names></name><name><surname>Chang</surname><given-names>T.I.</given-names></name><name><surname>Cushman</surname><given-names>W.C.</given-names></name><name><surname>Glasser</surname><given-names>S.P.</given-names></name><name><surname>Haley</surname><given-names>W.E.</given-names></name><name><surname>Johnson</surname><given-names>K.C.</given-names></name><name><surname>Kostis</surname><given-names>W.J.</given-names></name></person-group><article-title>Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT</article-title><source>J. Am. Heart Assoc.</source><year>2019</year><volume>8</volume><fpage>e011706</fpage><pub-id pub-id-type="doi">10.1161/JAHA.118.011706</pub-id><?supplied-pmid 31307270?><pub-id pub-id-type="pmid">31307270</pub-id></element-citation></ref><ref id="B31-nutrients-13-00798"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grossman</surname><given-names>E.</given-names></name></person-group><article-title>Ambulatory blood pressure monitoring in the diagnosis and management of hypertension</article-title><source>Diabetes Care</source><year>2013</year><volume>36</volume><fpage>S307</fpage><lpage>S311</lpage><pub-id pub-id-type="doi">10.2337/dcS13-2039</pub-id><?supplied-pmid 23882064?><pub-id pub-id-type="pmid">23882064</pub-id></element-citation></ref><ref id="B32-nutrients-13-00798"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grassi</surname><given-names>G.</given-names></name><name><surname>Turri</surname><given-names>C.</given-names></name><name><surname>Vailati</surname><given-names>S.</given-names></name><name><surname>Dell&#x02019;Oro</surname><given-names>R.</given-names></name><name><surname>Mancia</surname><given-names>G.</given-names></name></person-group><article-title>Muscle and skin sympathetic nerve traffic during the &#x0201c;white-coat&#x0201d; effect</article-title><source>Circulation</source><year>1999</year><volume>100</volume><fpage>222</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.100.3.222</pub-id><?supplied-pmid 10411843?><pub-id pub-id-type="pmid">10411843</pub-id></element-citation></ref><ref id="B33-nutrients-13-00798"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reagan-Shaw</surname><given-names>S.</given-names></name><name><surname>Nihal</surname><given-names>M.</given-names></name><name><surname>Ahmad</surname><given-names>N.</given-names></name></person-group><article-title>Dose translation from animal to human studies revisited</article-title><source>FASEB J.</source><year>2008</year><volume>22</volume><fpage>659</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1096/fj.07-9574LSF</pub-id><pub-id pub-id-type="pmid">17942826</pub-id></element-citation></ref><ref id="B34-nutrients-13-00798"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nurul-Iman</surname><given-names>B.S.</given-names></name><name><surname>Kamisah</surname><given-names>Y.</given-names></name><name><surname>Jaarin</surname><given-names>K.</given-names></name><name><surname>Qodriyah</surname><given-names>H.M.</given-names></name></person-group><article-title>Virgin coconut oil prevents blood pressure elevation and improves endothelial functions in rats fed with repeatedly heated palm oil</article-title><source>Evid. Based Complement. Alternat. Med.</source><year>2013</year><volume>2013</volume><fpage>629329</fpage><pub-id pub-id-type="doi">10.1155/2013/629329</pub-id><?supplied-pmid 23861707?><pub-id pub-id-type="pmid">23861707</pub-id></element-citation></ref><ref id="B35-nutrients-13-00798"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massaro</surname><given-names>M.</given-names></name><name><surname>Scoditti</surname><given-names>E.</given-names></name><name><surname>Carluccio</surname><given-names>M.A.</given-names></name><name><surname>Calabriso</surname><given-names>N.</given-names></name><name><surname>Santarpino</surname><given-names>G.</given-names></name><name><surname>Verri</surname><given-names>T.</given-names></name><name><surname>De Caterina</surname><given-names>R.</given-names></name></person-group><article-title>Effects of Olive Oil on Blood Pressure: Epidemiological, Clinical, and Mechanistic Evidence</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>1548</elocation-id><pub-id pub-id-type="doi">10.3390/nu12061548</pub-id><?supplied-pmid 32466599?><pub-id pub-id-type="pmid">32466599</pub-id></element-citation></ref><ref id="B36-nutrients-13-00798"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takagi</surname><given-names>T.</given-names></name><name><surname>Ohishi</surname><given-names>M.</given-names></name><name><surname>Ito</surname><given-names>N.</given-names></name><name><surname>Kaibe</surname><given-names>M.</given-names></name><name><surname>Tatara</surname><given-names>Y.</given-names></name><name><surname>Terai</surname><given-names>M.</given-names></name><name><surname>Shiota</surname><given-names>A.</given-names></name><name><surname>Hayashi</surname><given-names>N.</given-names></name><name><surname>Rakugi</surname><given-names>H.</given-names></name><name><surname>Ogihara</surname><given-names>T.</given-names></name></person-group><article-title>Evaluation of morning blood pressure elevation and autonomic nervous activity in hypertensive patients using wavelet transform of heart rate variability</article-title><source>Hypertens. Res.</source><year>2006</year><volume>29</volume><fpage>977</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1291/hypres.29.977</pub-id><pub-id pub-id-type="pmid">17378370</pub-id></element-citation></ref><ref id="B37-nutrients-13-00798"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancia</surname><given-names>G.</given-names></name><name><surname>Bombelli</surname><given-names>M.</given-names></name><name><surname>Facchetti</surname><given-names>R.</given-names></name><name><surname>Madotto</surname><given-names>F.</given-names></name><name><surname>Corrao</surname><given-names>G.</given-names></name><name><surname>Trevano</surname><given-names>F.Q.</given-names></name><name><surname>Grassi</surname><given-names>G.</given-names></name><name><surname>Sega</surname><given-names>R.</given-names></name></person-group><article-title>Long-term prognostic value of blood pressure variability in the general population: Results of the Pressioni Arteriose Monitorate e Loro Associazioni Study</article-title><source>Hypertension</source><year>2007</year><volume>49</volume><fpage>1265</fpage><lpage>1270</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.107.088708</pub-id><pub-id pub-id-type="pmid">17452502</pub-id></element-citation></ref><ref id="B38-nutrients-13-00798"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lodhi</surname><given-names>H.A.</given-names></name><name><surname>Peri-Okonny</surname><given-names>P.A.</given-names></name><name><surname>Schesing</surname><given-names>K.</given-names></name><name><surname>Phelps</surname><given-names>K.</given-names></name><name><surname>Ngo</surname><given-names>C.</given-names></name><name><surname>Evans</surname><given-names>H.</given-names></name><name><surname>Arbique</surname><given-names>D.</given-names></name><name><surname>Price</surname><given-names>A.L.</given-names></name><name><surname>Vernino</surname><given-names>S.</given-names></name><name><surname>Phillips</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Usefulness of Blood Pressure Variability Indices Derived From 24-Hour Ambulatory Blood Pressure Monitoring in Detecting Autonomic Failure</article-title><source>J. Am. Heart Assoc.</source><year>2019</year><volume>8</volume><fpage>e010161</fpage><pub-id pub-id-type="doi">10.1161/JAHA.118.010161</pub-id><pub-id pub-id-type="pmid">30905258</pub-id></element-citation></ref><ref id="B39-nutrients-13-00798"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>P.F.</given-names></name><name><surname>Cheng</surname><given-names>H.M.</given-names></name><name><surname>Wu</surname><given-names>C.H.</given-names></name><name><surname>Sung</surname><given-names>S.H.</given-names></name><name><surname>Chuang</surname><given-names>S.Y.</given-names></name><name><surname>Lakatta</surname><given-names>E.G.</given-names></name><name><surname>Yin</surname><given-names>F.C.</given-names></name><name><surname>Chou</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>C.H.</given-names></name></person-group><article-title>High Short-Term Blood Pressure Variability Predicts Long-Term Cardiovascular Mortality in Untreated Hypertensives But Not in Normotensives</article-title><source>Am. J. Hypertens.</source><year>2016</year><volume>29</volume><fpage>806</fpage><lpage>813</lpage><pub-id pub-id-type="doi">10.1093/ajh/hpw002</pub-id><pub-id pub-id-type="pmid">26837643</pub-id></element-citation></ref><ref id="B40-nutrients-13-00798"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothwell</surname><given-names>P.M.</given-names></name></person-group><article-title>Does blood pressure variability modulate cardiovascular risk?</article-title><source>Curr. Hypertens. Rep.</source><year>2011</year><volume>13</volume><fpage>177</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1007/s11906-011-0201-3</pub-id><pub-id pub-id-type="pmid">21465141</pub-id></element-citation></ref><ref id="B41-nutrients-13-00798"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Floras</surname><given-names>J.S.</given-names></name></person-group><article-title>Blood pressure variability: A novel and important risk factor</article-title><source>Can. J. Cardiol.</source><year>2013</year><volume>29</volume><fpage>557</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1016/j.cjca.2013.02.012</pub-id><?supplied-pmid 23618505?><pub-id pub-id-type="pmid">23618505</pub-id></element-citation></ref><ref id="B42-nutrients-13-00798"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parati</surname><given-names>G.</given-names></name><name><surname>Ochoa</surname><given-names>J.E.</given-names></name><name><surname>Lombardi</surname><given-names>C.</given-names></name><name><surname>Bilo</surname><given-names>G.</given-names></name></person-group><article-title>Assessment and management of blood-pressure variability</article-title><source>Nat. Rev. Cardiol.</source><year>2013</year><volume>10</volume><fpage>143</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1038/nrcardio.2013.1</pub-id><?supplied-pmid 23399972?><pub-id pub-id-type="pmid">23399972</pub-id></element-citation></ref><ref id="B43-nutrients-13-00798"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagonas</surname><given-names>N.</given-names></name><name><surname>Dimeo</surname><given-names>F.</given-names></name><name><surname>Bauer</surname><given-names>F.</given-names></name><name><surname>Seibert</surname><given-names>F.</given-names></name><name><surname>Kiziler</surname><given-names>F.</given-names></name><name><surname>Zidek</surname><given-names>W.</given-names></name><name><surname>Westhoff</surname><given-names>T.H.</given-names></name></person-group><article-title>The impact of aerobic exercise on blood pressure variability</article-title><source>J. Hum. Hypertens.</source><year>2014</year><volume>28</volume><fpage>367</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1038/jhh.2013.121</pub-id><?supplied-pmid 24284387?><pub-id pub-id-type="pmid">24284387</pub-id></element-citation></ref><ref id="B44-nutrients-13-00798"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baghaiee</surname><given-names>B.</given-names></name><name><surname>Karimi</surname><given-names>P.</given-names></name><name><surname>Ebrahimi</surname><given-names>K.</given-names></name><name><surname>Dabagh Nikoo Kheslat</surname><given-names>S.</given-names></name><name><surname>Sadeghi Zali</surname><given-names>M.H.</given-names></name><name><surname>Daneshian Moghaddam</surname><given-names>A.M.</given-names></name><name><surname>Sadaghian</surname><given-names>M.</given-names></name></person-group><article-title>Effects of a 12-week aerobic exercise on markers of hypertension in men</article-title><source>J. Cardiovasc. Thorac. Res.</source><year>2018</year><volume>10</volume><fpage>162</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.15171/jcvtr.2018.26</pub-id><pub-id pub-id-type="pmid">30386537</pub-id></element-citation></ref><ref id="B45-nutrients-13-00798"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marina</surname><given-names>A.M.</given-names></name><name><surname>Che Man</surname><given-names>Y.B.</given-names></name><name><surname>Amin</surname><given-names>I.</given-names></name></person-group><article-title>Chemical Properties of Virgin Coconut Oil | SpringerLink</article-title><source>J. Am. Oil Chem. Soc.</source><year>2009</year><volume>86</volume><fpage>301</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1007/s11746-009-1351-1</pub-id></element-citation></ref><ref id="B46-nutrients-13-00798"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vysakh</surname><given-names>A.</given-names></name><name><surname>Ratheesh</surname><given-names>M.</given-names></name><name><surname>Rajmohanan</surname><given-names>T.P.</given-names></name><name><surname>Pramod</surname><given-names>C.</given-names></name><name><surname>Premlal</surname><given-names>S.</given-names></name><name><surname>Sibi</surname><given-names>P.I.</given-names></name></person-group><article-title>Polyphenolics isolated from virgin coconut oil inhibits adjuvant induced arthritis in rats through antioxidant and anti-inflammatory action</article-title><source>Int. Immunopharmacol.</source><year>2014</year><volume>20</volume><fpage>124</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2014.02.026</pub-id><?supplied-pmid 24613207?><pub-id pub-id-type="pmid">24613207</pub-id></element-citation></ref><ref id="B47-nutrients-13-00798"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Briones</surname><given-names>A.M.</given-names></name><name><surname>Touyz</surname><given-names>R.M.</given-names></name></person-group><article-title>Oxidative stress and hypertension: Current concepts</article-title><source>Curr. Hypertens. Rep.</source><year>2010</year><volume>12</volume><fpage>135</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1007/s11906-010-0100-z</pub-id><pub-id pub-id-type="pmid">20424957</pub-id></element-citation></ref><ref id="B48-nutrients-13-00798"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baradaran</surname><given-names>A.</given-names></name><name><surname>Nasri</surname><given-names>H.</given-names></name><name><surname>Rafieian-Kopaei</surname><given-names>M.</given-names></name></person-group><article-title>Oxidative stress and hypertension: Possibility of hypertension therapy with antioxidants</article-title><source>J. Res. Med. Sci.</source><year>2014</year><volume>19</volume><fpage>358</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">25097610</pub-id></element-citation></ref><ref id="B49-nutrients-13-00798"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruno</surname><given-names>R.M.</given-names></name><name><surname>Ghiadoni</surname><given-names>L.</given-names></name></person-group><article-title>Polyphenols, Antioxidants and the Sympathetic Nervous System</article-title><source>Curr. Pharm. Des.</source><year>2018</year><volume>24</volume><fpage>130</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.2174/1381612823666171114170642</pub-id><pub-id pub-id-type="pmid">29141540</pub-id></element-citation></ref><ref id="B50-nutrients-13-00798"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salim</surname><given-names>S.</given-names></name></person-group><article-title>Oxidative Stress and the Central Nervous System</article-title><source>J. Pharmacol. Exp. Ther.</source><year>2017</year><volume>360</volume><fpage>201</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1124/jpet.116.237503</pub-id><pub-id pub-id-type="pmid">27754930</pub-id></element-citation></ref><ref id="B51-nutrients-13-00798"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuern</surname><given-names>C.S.</given-names></name><name><surname>Rizas</surname><given-names>K.D.</given-names></name><name><surname>Eick</surname><given-names>C.</given-names></name><name><surname>Stoleriu</surname><given-names>C.</given-names></name><name><surname>Bunk</surname><given-names>L.</given-names></name><name><surname>Barthel</surname><given-names>P.</given-names></name><name><surname>Balletshofer</surname><given-names>B.</given-names></name><name><surname>Gawaz</surname><given-names>M.</given-names></name><name><surname>Bauer</surname><given-names>A.</given-names></name></person-group><article-title>Effects of renal sympathetic denervation on 24-hour blood pressure variability</article-title><source>Front. Physiol.</source><year>2012</year><volume>3</volume><fpage>134</fpage><pub-id pub-id-type="doi">10.3389/fphys.2012.00134</pub-id><?supplied-pmid 22590460?><pub-id pub-id-type="pmid">22590460</pub-id></element-citation></ref><ref id="B52-nutrients-13-00798"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabitha</surname><given-names>P.</given-names></name><name><surname>Vaidyanathan</surname><given-names>K.</given-names></name><name><surname>Vasudevan</surname><given-names>D.M.</given-names></name><name><surname>Kamath</surname><given-names>P.</given-names></name></person-group><article-title>Comparison of lipid profile and antioxidant enzymes among south Indian men consuming coconut oil and sunflower oil</article-title><source>Indian J. Clin. Biochem.</source><year>2009</year><volume>24</volume><fpage>76</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1007/s12291-009-0013-2</pub-id><?supplied-pmid 23105811?><pub-id pub-id-type="pmid">23105811</pub-id></element-citation></ref><ref id="B53-nutrients-13-00798"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ristow</surname><given-names>M.</given-names></name><name><surname>Zarse</surname><given-names>K.</given-names></name><name><surname>Oberbach</surname><given-names>A.</given-names></name><name><surname>Kl&#x000f6;ting</surname><given-names>N.</given-names></name><name><surname>Birringer</surname><given-names>M.</given-names></name><name><surname>Kiehntopf</surname><given-names>M.</given-names></name><name><surname>Stumvoll</surname><given-names>M.</given-names></name><name><surname>Kahn</surname><given-names>C.R.</given-names></name><name><surname>Bl&#x000fc;her</surname><given-names>M.</given-names></name></person-group><article-title>Antioxidants prevent health-promoting effects of physical exercise in humans</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2009</year><volume>106</volume><fpage>8665</fpage><lpage>8670</lpage><pub-id pub-id-type="doi">10.1073/pnas.0903485106</pub-id><?supplied-pmid 19433800?><pub-id pub-id-type="pmid">19433800</pub-id></element-citation></ref><ref id="B54-nutrients-13-00798"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farinha</surname><given-names>J.B.</given-names></name><name><surname>Steckling</surname><given-names>F.M.</given-names></name><name><surname>Stefanello</surname><given-names>S.T.</given-names></name><name><surname>Cardoso</surname><given-names>M.S.</given-names></name><name><surname>Nunes</surname><given-names>L.S.</given-names></name><name><surname>Barcelos</surname><given-names>R.P.</given-names></name><name><surname>Duarte</surname><given-names>T.</given-names></name><name><surname>Kretzmann</surname><given-names>N.A.</given-names></name><name><surname>Mota</surname><given-names>C.B.</given-names></name><name><surname>Bresciani</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Response of oxidative stress and inflammatory biomarkers to a 12-week aerobic exercise training in women with metabolic syndrome</article-title><source>Sports Med.</source><year>2015</year><volume>1</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1186/s40798-015-0011-2</pub-id><?supplied-pmid 26284160?><pub-id pub-id-type="pmid">26284160</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="nutrients-13-00798-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flowchart of the study design.</p></caption><graphic xlink:href="nutrients-13-00798-g001"/></fig><fig id="nutrients-13-00798-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Comparison of mean blood pressure levels between experimental groups. Data expressed as means and SD (<italic>n</italic> = 43). Mean Arterial Pressure (MAP). One-way ANCOVA of repeated measures corrected for age: Time factor (<italic>p</italic> = 0.119 and <italic>&#x003b7;</italic><sup>2</sup> = 0.063) and Group factor (<italic>p</italic> = 0.482 and <italic>&#x003b7;</italic><sup>2</sup> = 0.062). There were no significant interaction of effects (<italic>p</italic> = 0.446 and <italic>&#x003b7;</italic><sup>2</sup> = 0.067).</p></caption><graphic xlink:href="nutrients-13-00798-g002"/></fig><fig id="nutrients-13-00798-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Comparison of serum malondialdehyde concentrations in hypertensive patients after 30 days of supplementation with EVCO or placebo, combined or not with aerobic physical training. One-way ANCOVA of repeated measures corrected for age, followed by a Bonferroni <italic>post-test</italic> (<italic>n</italic> = 45): time factor (<italic>p</italic> = 0.559 and <italic>&#x003b7;</italic><sup>2</sup> = 0.009); group factor (<italic>p</italic> = 0.644 and <italic>&#x003b7;</italic><sup>2</sup> = 0.04) and interaction factor (<italic>p</italic> = 0.015 and <italic>&#x003b7;</italic><sup>2</sup> = 0.227). * Post hoc for interaction: <italic>p</italic> = 0.001 (EVCO-training group).</p></caption><graphic xlink:href="nutrients-13-00798-g003"/></fig><fig id="nutrients-13-00798-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Comparison of the blood pressure variability in hypertensive patients after 30 days of supplementation with EVCO or placebo, combined or not with aerobic physical training. One-way ANCOVA of repeated measures corrected for age (<italic>n</italic> = 43). (<bold>A</bold>) SD&#x02013;MAP: (Time factor (<italic>p</italic> = 0.696 and <italic>&#x003b7;</italic><sup>2</sup> 0.004); group factor (<italic>p</italic> = 0.595 and <italic>&#x003b7;</italic><sup>2</sup> = 0.048); and interaction factor (<italic>p</italic> = 0.233 and <italic>&#x003b7;</italic><sup>2</sup> = 0.105). (<bold>B</bold>) ARV&#x02013;MAP: (Time factor (<italic>p</italic> = 0.848 and <italic>&#x003b7;</italic><sup>2</sup> 0.001); group factor (<italic>p</italic> = 0.673 and <italic>&#x003b7;</italic><sup>2</sup> = 0.039); and interaction factor (<italic>p</italic> = 0.434 and <italic>&#x003b7;</italic><sup>2</sup> = 0.069).</p></caption><graphic xlink:href="nutrients-13-00798-g004"/></fig><table-wrap id="nutrients-13-00798-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-13-00798-t001_Table 1</object-id><label>Table 1</label><caption><p>Nutritional information on coconut oil supplementation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Nutritional Constituents</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Quantity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dv % *</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Total calories (Kcal)</td><td align="center" valign="middle" rowspan="1" colspan="1">90</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Total fats (g)</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Saturated fats (g)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.5</td><td align="center" valign="middle" rowspan="1" colspan="1">35</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Monounsaturated fats (g)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.5</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lauric acid (g)</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Myristic acid (g)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.5</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oleic acid (g)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">**</td></tr></tbody></table><table-wrap-foot><fn><p>Equivalent to the content of 10 capsules with extra virgin coconut oil. * Percentages of daily values in relation to a 2000 kcal diet. ** Daily values not established.</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-13-00798-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-13-00798-t002_Table 2</object-id><label>Table 2</label><caption><p>Baseline clinical characteristics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Baseline<break/>Parameters</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">EVCO<break/>(<italic>n</italic> = 14)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Placebo<break/>(<italic>n</italic> = 11)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">EVCO <italic>plus</italic> Training<break/>(<italic>n</italic> = 11)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Placebo <italic>plus</italic> Training<break/>(<italic>n</italic> = 9)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic> Valor</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Men <italic>n</italic> (%) &#x02020;</td><td align="center" valign="middle" rowspan="1" colspan="1">7 (46.0%)</td><td align="center" valign="middle" rowspan="1" colspan="1">7 (63.0%)</td><td align="center" valign="middle" rowspan="1" colspan="1">8 (73%)</td><td align="center" valign="middle" rowspan="1" colspan="1">7 (88%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.390</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age (years)</td><td align="center" valign="middle" rowspan="1" colspan="1">49.6 &#x000b1; 9.9</td><td align="center" valign="middle" rowspan="1" colspan="1">35.0 &#x000b1; 9.3</td><td align="center" valign="middle" rowspan="1" colspan="1">42.8 &#x000b1; 9.0</td><td align="center" valign="middle" rowspan="1" colspan="1">37.0 &#x000b1; 12.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.006 #</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BMI</td><td align="center" valign="middle" rowspan="1" colspan="1">29.8 &#x000b1; 5.8</td><td align="center" valign="middle" rowspan="1" colspan="1">28.6 &#x000b1; 5.4</td><td align="center" valign="middle" rowspan="1" colspan="1">27.9 &#x000b1; 4.7</td><td align="center" valign="middle" rowspan="1" colspan="1">31.4 &#x000b1; 4.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.622</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Total cholesterol</td><td align="center" valign="middle" rowspan="1" colspan="1">198.6 &#x000b1; 36.3</td><td align="center" valign="middle" rowspan="1" colspan="1">163.2 &#x000b1; 36.3</td><td align="center" valign="middle" rowspan="1" colspan="1">195.0 &#x000b1; 48.5</td><td align="center" valign="middle" rowspan="1" colspan="1">197.1 &#x000b1; 85.5</td><td align="center" valign="middle" rowspan="1" colspan="1">0.433</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HDL-cholesterol</td><td align="center" valign="middle" rowspan="1" colspan="1">38.9 &#x000b1; 12.7</td><td align="center" valign="middle" rowspan="1" colspan="1">45.7 &#x000b1; 13.0</td><td align="center" valign="middle" rowspan="1" colspan="1">55.2 &#x000b1; 10.3</td><td align="center" valign="middle" rowspan="1" colspan="1">38.4 &#x000b1; 12.9</td><td align="center" valign="middle" rowspan="1" colspan="1">0.009#</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LDL-cholesterol</td><td align="center" valign="middle" rowspan="1" colspan="1">82.2 &#x000b1; 8.8</td><td align="center" valign="middle" rowspan="1" colspan="1">60.7 &#x000b1; 16.1</td><td align="center" valign="middle" rowspan="1" colspan="1">94.6 &#x000b1; 26.2</td><td align="center" valign="middle" rowspan="1" colspan="1">77.2 &#x000b1; 27.9</td><td align="center" valign="middle" rowspan="1" colspan="1">0.039#</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Non-HDL cholesterol</td><td align="center" valign="middle" rowspan="1" colspan="1">167.3 &#x000b1; 59.3</td><td align="center" valign="middle" rowspan="1" colspan="1">117.5 &#x000b1; 34.9</td><td align="center" valign="middle" rowspan="1" colspan="1">139.7 &#x000b1; 50.1</td><td align="center" valign="middle" rowspan="1" colspan="1">158.6 &#x000b1; 84.4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.355</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Triglycerides</td><td align="center" valign="middle" rowspan="1" colspan="1">158.6 &#x000b1; 66.2</td><td align="center" valign="middle" rowspan="1" colspan="1">108.6 &#x000b1; 47.0</td><td align="center" valign="middle" rowspan="1" colspan="1">168.1 &#x000b1; 51.3</td><td align="center" valign="middle" rowspan="1" colspan="1">148.4 &#x000b1; 97.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.299</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Glucose</td><td align="center" valign="middle" rowspan="1" colspan="1">89.2 &#x000b1; 13.1</td><td align="center" valign="middle" rowspan="1" colspan="1">82.2 &#x000b1; 12.8</td><td align="center" valign="middle" rowspan="1" colspan="1">90.9 &#x000b1; 10.0</td><td align="center" valign="middle" rowspan="1" colspan="1">89.5 &#x000b1; 14.4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.492</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MDA <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.29 &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">2.18 &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">2.65 &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">2.16 &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.012 #</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SAP <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">134.6 &#x000b1; 8.2</td><td align="center" valign="middle" rowspan="1" colspan="1">131.3 &#x000b1; 9.1</td><td align="center" valign="middle" rowspan="1" colspan="1">134.2 &#x000b1; 8.6</td><td align="center" valign="middle" rowspan="1" colspan="1">132.1 &#x000b1; 6.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.303</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DAP <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">87.7 &#x000b1; 8.1</td><td align="center" valign="middle" rowspan="1" colspan="1">88.8 &#x000b1; 9.9</td><td align="center" valign="middle" rowspan="1" colspan="1">89.9 &#x000b1; 6.6</td><td align="center" valign="middle" rowspan="1" colspan="1">88.0 &#x000b1; 4.4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.898</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MAP <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">103.2 &#x000b1; 7.2</td><td align="center" valign="middle" rowspan="1" colspan="1">102.7 &#x000b1; 9.0</td><td align="center" valign="middle" rowspan="1" colspan="1">104.5 &#x000b1; 6.2</td><td align="center" valign="middle" rowspan="1" colspan="1">102.5 &#x000b1; 3.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.765</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SD-MAP <sup>e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">9.3 &#x000b1; 1.6</td><td align="center" valign="middle" rowspan="1" colspan="1">8.9 &#x000b1; 1.9</td><td align="center" valign="middle" rowspan="1" colspan="1">10.2 &#x000b1; 2.2</td><td align="center" valign="middle" rowspan="1" colspan="1">9.3 &#x000b1; 1.9</td><td align="center" valign="middle" rowspan="1" colspan="1">0.552</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ARV-MAP <sup>f</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">6.5 &#x000b1; 1.3</td><td align="center" valign="middle" rowspan="1" colspan="1">6.1 &#x000b1; 0.9</td><td align="center" valign="middle" rowspan="1" colspan="1">6.5 &#x000b1; 1.3</td><td align="center" valign="middle" rowspan="1" colspan="1">6.4 &#x000b1; 0.7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.898</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VO<sub>2</sub>max <sup>g</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43.4 &#x000b1; 5.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39.8 &#x000b1; 4.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.140</td></tr></tbody></table><table-wrap-foot><fn><p>(HDL) = High Density Lipoprotein; (LDL) = Low-density lipoprotein; others lipidic profile parameters and glucose expressed in (mg/dL). BMI = Body Mass Index (kg/m<sup>2</sup>). <sup>a</sup> The values of malondialdehyde (MDA) are expressed in log (nmol/mL); <sup>b</sup>, <sup>c</sup> and <sup>d</sup> Mean values of systolic (SAP), diastolic (DAP) and mean blood pressure (MAP) (mmHg) obtained in awake patients using 24-hour blood pressure monitoring, respectively; and <sup>e</sup> Standard deviation (SD) and <sup>f</sup> Average real variability (AVR) of the mean arterial pressure (mmHg); <sup>g</sup> (VO<sub>2</sub>max) = Maximum oxygen consumption (mL&#x000b7;kg<sup>&#x02212;1</sup>&#x000b7;min<sup>&#x02212;1</sup>) estimated by 1-mile field test for the patients in the training protocol. Data expressed as mean &#x000b1; standard deviation or n(%); &#x02020; Person Chi-square test; # Significance by ANOVA one-way for group factor and Post Hoc tests(Age: EVCO vs. Placebo (<italic>p</italic> = 0.008) and EVCO vs. Placebo-Training (<italic>p</italic> = 0.043); HDL: EVCO vs. EVCO-Training (<italic>p</italic> = 0.013) and EVCO-Training vs. Placebo-Training (<italic>p</italic> = 0.026); LDL: Placebo vs. EVCO-Training (<italic>p</italic> = 0.013); MDA: EVCO vs. EVCO-Training (<italic>p</italic> = 0.042) and EVCO -Training vs. Placebo-Training (<italic>p</italic> = 0.028).</p></fn></table-wrap-foot></table-wrap></floats-group></article>